Penumbra is expected to give Boston Scientific more of a presence in the vascular surgery market, with little overlap between ...

What Happened? Shares of medical device company Penumbra (NYSE:PEN) jumped 12.1% in the afternoon session after the company ...

Penumbra (PEN) climbs on strong Q4 results and acquisition agreement with Boston Scientific (BSX), deal valued at $14.5B.

Boston Scientific has agreed to buy thrombectomy company Penumbra for about $15 billion in cash and stock in a deal that ...

With its release date creeping ever closer, the official website for Penumbra: Black Plague has now been unveiled by Paradox Interactive. Black Plague is the second (and final) part of the ...

Bank of America launched its coverage of medical device maker Penumbra (NYSE:PEN) with a Buy recommendation on Friday, citing a broader commercial rollout of the company’s latest clot-removal product, ...

Penumbra PEN shares ended the last trading session 6.2% higher at $197.49. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This ...

The 12-month price targets, analyzed by analysts, offer insights with an average target of $353.86, a high estimate of $388.00, and a low estimate of $275.00. Marking an increase of 10.32%, the ...

In this article we will check out the progression of hedge fund sentiment towards Penumbra Inc (NYSE:PEN) and determine whether it is a good investment right now. We at Insider Monkey like to examine ...